Sam Chun Dang Pharm Overview
- Founded
-
1943
- Status
-
Public
- Employees
-
392
- Stock Symbol
-
000250
- Investments
-
1
- Share Price
-
$25.35
- (As of Tuesday Closing)
Sam Chun Dang Pharm General Information
Description
Samchundang Pharm Co Ltd is engaged in manufacturing, distributing, importing, and exporting pharmaceuticals in South Korea. The company offers ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as gastro intestines and vitamins.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Stock Exchange
KRX
Primary Office
- 1606-1 Seocho-dong, Seocho-gu
- Seoul, 137-877
- South Korea
+82 00-0000-0000
Sam Chun Dang Pharm Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $25.35 | $23.96 | $23.43 - $56.03 | $529M | 22.1M | 167K | -$0.41 |
Sam Chun Dang Pharm Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 688,987 | 825,509 | 1,657,285 | 648,781 |
| Revenue | 145,158 | 146,038 | 141,325 | 160,026 |
| EBITDA | (3,652) | (10,780) | 18,865 | 21,090 |
| Net Income | (8,968) | (14,453) | (818) | 8,963 |
| Total Assets | 298,578 | 289,027 | 290,653 | 250,486 |
| Total Debt | 59,636 | 43,311 | 24,818 | 20,592 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Sam Chun Dang Pharm Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sam Chun Dang Pharm Patents
Sam Chun Dang Pharm Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2019517513-A | Ophthalmic pharmaceutical composition | Granted | 26-Apr-2017 | 0000000000 | |
| JP-6677827-B2 | Ophthalmic pharmaceutical composition | Active | 26-Apr-2017 | 0000000000 | |
| EP-3452075-B1 | Ophthalmic pharmaceutical composition | Active | 26-Apr-2017 | 0000000000 | |
| US-20190160145-A1 | Ophthalmic pharmaceutical composition | Granted | 26-Apr-2017 | 0000000000 | |
| EP-3452075-A1 | Ophthalmic pharmaceutical composition | Granted | 26-Apr-2017 | A61K38/179 |
Sam Chun Dang Pharm Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jeon-Kyo Park | President & Chief Executive Officer | ||
| Jeon In-Seok | Senior Managing Director | ||
| Kim Dae-Wook | Senior Managing Director |
Sam Chun Dang Pharm Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Sam Chun Dang Pharm Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000 00000 | 27-Dec-2012 | 0000000000 | 0000 | Pharmaceuticals |
Sam Chun Dang Pharm Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 000 00000 | Pharmaceuticals | Seoul, South Korea | 0000 |